Boston Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $3.14M | Sell |
18,552
-248
| -1% | -$42K | 0.16% | 166 |
|
|
2019
Q2 | $3.45M | Sell |
18,800
-8,648
| -32% | -$1.59M | 0.18% | 150 |
|
|
2019
Q1 | $5.05M | Sell |
27,448
-8,333
| -23% | -$1.53M | 0.26% | 109 |
|
|
2018
Q4 | $5.93M | Sell |
35,781
-1,879
| -5% | -$311K | 0.34% | 69 |
|
|
2018
Q3 | $7.26M | Sell |
37,660
-181,726
| -83% | -$35M | 0.31% | 80 |
|
|
2018
Q2 | $37.3M | Buy |
219,386
+79,212
| +57% | +$13.5M | 0.93% | 13 |
|
|
2018
Q1 | $22.8M | Buy |
140,174
+24,054
| +21% | +$3.92M | 0.59% | 42 |
|
|
2017
Q4 | $17.4M | Buy |
+116,120
| New | +$17.4M | 0.38% | 74 |
|
|
2017
Q1 | – | Sell |
-183,040
| Closed | -$13.5M | – | 670 |
|
|
2016
Q4 | $13.5M | Sell |
183,040
-5,205
| -3% | -$383K | 0.32% | 93 |
|
|
2016
Q3 | $16.4M | Buy |
+188,245
| New | +$16.4M | 0.41% | 80 |
|